IC
ABBV icon

InterOcean Capital’s AbbVie ABBV Stock Holding History

InterOcean Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$540K Hold
5,503
– – 0.04% 106
2020
Q1 		$419K Sell
5,503
-5,220
-49% -$445K 0.04% 118
2019
Q4 		$949K Buy
10,723
+517
+5% +$42.9K 0.07% 107
2019
Q3 		$773K Buy
10,206
+561
+6% +$38.5K 0.06% 112
2019
Q2 		$701K Sell
9,645
-135
-1% -$10.6K 0.06% 110
2019
Q1 		$788K Sell
9,780
-141
-1% -$11.5K 0.07% 100
2018
Q4 		$915K Buy
9,921
+411
+4% +$36.1K 0.1% 95
2018
Q3 		$899K Buy
9,510
+615
+7% +$58.3K 0.09% 101
2018
Q2 		$824K Buy
8,895
+2,178
+32% +$213K 0.1% 101
2018
Q1 		$636K Sell
6,717
-3,700
-36% -$406K 0.08% 104
2017
Q4 		$1.01M Hold
10,417
– – 0.14% 80
2017
Q3 		$926K Hold
10,417
– – 0.14% 77
2017
Q2 		$755K Buy
10,417
+5,000
+92% +$336K 0.12% 81
2017
Q1 		$353K Buy
5,417
+211
+4% +$13.3K 0.07% 107
2016
Q4 		$326K Sell
5,206
-100
-2% -$6.1K 0.07% 112
2016
Q3 		$335K Buy
5,306
+628
+13% +$40.7K 0.08% 110
2016
Q2 		$290K Sell
4,678
-1,585
-25% -$96.6K 0.07% 115
2016
Q1 		$358K Buy
6,263
+1,170
+23% +$65.2K 0.1% 94
2015
Q4 		$302K Buy
5,093
+93
+2% +$5.36K 0.1% 106
2015
Q3 		$272K Sell
5,000
-400
-7% -$26K 0.1% 119
2015
Q2 		$363K Sell
5,400
-2,183
-29% -$143K 0.11% 99
2015
Q1 		$444K Buy
7,583
+2,971
+64% +$179K 0.15% 83
2014
Q4 		$302K Sell
4,612
-3,995
-46% -$252K 0.11% 101
2014
Q3 		$497K Buy
8,607
+2,904
+51% +$161K 0.19% 70
2014
Q2 		$322K Buy
5,703
+900
+19% +$47.2K 0.1% 99
2014
Q1 		$247K Buy
4,803
+300
+7% +$15.2K 0.11% 91
2013
Q4 		$238K Buy
+4,503
New +$221K 0.1% 87

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

InterOcean Capital's ABBV Position: Q2 2020 in Review

InterOcean Capital held its AbbVie (ABBV) position steady in Q2 2020 at 5,503 shares worth $540K. The position accounts for 0.04% of the portfolio, ranked #106.

InterOcean Capital first reported a position in ABBV in Q4 2013 and has held it in 27 quarters since. The position peaked at $1.01M in Q4 2017. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • InterOcean Capital held 5,503 shares of AbbVie worth $540K as of Q2 2020.
  • InterOcean Capital left its AbbVie share count unchanged in Q2 2020.
  • AbbVie made up 0.04% of InterOcean Capital's portfolio in Q2 2020, its #106 holding.
  • InterOcean Capital first reported a position in AbbVie in Q4 2013 and has held it in 27 quarters since.
  • InterOcean Capital's AbbVie position peaked at $1.01M in Q4 2017.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on InterOcean Capital's 13F filing for Q2 2020, filed 13 Aug 2020.